189 related articles for article (PubMed ID: 11881788)
21. Therapeutic value of black seed oil in methotrexate hepatotoxicity in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; AbdElaal AM; Elfaragy MS; Hassan SM; Elzamarany EA
Infect Disord Drug Targets; 2015; 15(1):64-71. PubMed ID: 25809628
[TBL] [Abstract][Full Text] [Related]
22. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
Tsao TF; Chao YH
Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
[No Abstract] [Full Text] [Related]
23. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
24. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?
Cohen IJ; Wolff JE
Pediatr Blood Cancer; 2014 Jan; 61(1):7-10. PubMed ID: 24038885
[TBL] [Abstract][Full Text] [Related]
25. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
[TBL] [Abstract][Full Text] [Related]
26. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
[TBL] [Abstract][Full Text] [Related]
27. Late-onset delayed excretion of methotrexate.
Pauley JL; Panetta JC; Schmidt J; Kornegay N; Relling MV; Pui CH
Cancer Chemother Pharmacol; 2004 Aug; 54(2):146-52. PubMed ID: 15148625
[TBL] [Abstract][Full Text] [Related]
28. Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
Oosterom N; Griffioen PH; den Hoed MAH; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
PLoS One; 2018; 13(7):e0199574. PubMed ID: 29985926
[TBL] [Abstract][Full Text] [Related]
29. Glucarpidase treatment for methotrexate intoxication: a case report and review of the literature.
Boelens AD; Mathôt RAA; Vlaar APJ; Bouman CSC
Neth J Med; 2018 Jan; 76(1):36-39. PubMed ID: 29380731
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate sodium-associated UV reactivation in a patient with acute lymphoblastic leukemia.
Yankura J; Saddic N; Jones CR; Adams DR
Cutis; 2012 May; 89(5):233-6. PubMed ID: 22768437
[TBL] [Abstract][Full Text] [Related]
31. Acral erythema in children receiving high-dose methotrexate.
Millot F; Auriol F; Brecheteau P; Guilhot F
Pediatr Dermatol; 1999; 16(5):398-400. PubMed ID: 10571844
[TBL] [Abstract][Full Text] [Related]
32. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
33. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
[TBL] [Abstract][Full Text] [Related]
34. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.
Peyriere H; Poiree M; Cociglio M; Margueritte G; Hansel S; Hillaire-Buys D
Med Pediatr Oncol; 2001 Jun; 36(6):662-4. PubMed ID: 11344503
[No Abstract] [Full Text] [Related]
35. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
von Poblozki A; Dempke W; Schmoll HJ
Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069
[TBL] [Abstract][Full Text] [Related]
36. Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate.
Zhang HN; He XL; Wang C; Wang Y; Chen YJ; Li JX; Niu CH; Gao P
Pediatr Blood Cancer; 2014 Dec; 61(12):2203-7. PubMed ID: 25130190
[TBL] [Abstract][Full Text] [Related]
37. Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia.
Al-Sheikh A; Yousef AM; Alshamaseen D; Farhad R
Cancer Chemother Pharmacol; 2021 Mar; 87(3):379-385. PubMed ID: 33170323
[TBL] [Abstract][Full Text] [Related]
38. Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia.
Lau KK; Weiss AR; Jones DP
J Oncol Pharm Pract; 2005 Mar; 11(1):31-3. PubMed ID: 16460601
[TBL] [Abstract][Full Text] [Related]
39. Transient encephalopathy following high-dose methotrexate.
Lee AC; Li CH; Wong YC
Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
[No Abstract] [Full Text] [Related]
40. Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia.
van den Bos C; Bierings MB; Bruin MC; Rademaker CM; van Haselen CW; Révész T
Med Pediatr Oncol; 2000 Apr; 34(4):278-80. PubMed ID: 10742071
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
